RNS Number:0174T
Celsis International PLC
24 April 2008


For filings with the FSA include the annex
For filings with issuer exclude the annex


TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which 
voting rights are attached:

CELSIS INTERNATIONAL PLC

2. Reason for notification 
(please place an X inside the appropriate bracket/s):

An acquisition or disposal of voting rights:                               (YES)

An acquisition or disposal of financial instruments which may result in the 
acquisition of shares already issued to which voting rights are attached:  (NO)

An event changing the breakdown of voting rights:                          (NO)

Other (please specify) :                                                   (  )


3. Full name of person(s) subject to notification obligation:

LOEB PARTNERS CORPORATION

4. Full name of shareholder(s) (if different from 3) :

(AS ABOVE)

5. Date of transaction (and date on which the threshold is crossed or reached 
if different):

17 APRIL 2008

6. Date on which issuer notified:

21 APRIL 2008

7. Threshold(s) that is/are crossed or reached:

6%

8. Notified Details:

A: Voting rights attached to shares
 
Class/type of shares              Situation previous to  
if possible use                 the Triggering transaction                
ISIN CODE                       
                       Number of shares       Number of voting Rights 

GB000B0CD5F69              1,325,622              1,325,622

 

                            Resulting situation after the triggering transaction 
 
Class/type of shares   Number of shares  Number of voting rights    % of voting rights  
if possible use                                                                 
ISIN CODE                                Direct     Indirect        Direct    Indirect  


GB000B0CD5F69            1,300,622       1,300,622      -            6.00% 

B: Financial Instruments

Resulting situation after the triggering transaction 

Type of     Expiration date  Exercise/conversion  No. of voting     % of voting     
financial                    period/date          rights that may   rights          
instrument                                        be acquired (if                       
                                                  the instrument                         
                                                  exercised/
                                                  converted)                           

N/A

Total (A+B)
Number of voting rights       % of voting rights 

1,300,622                         5.89%


9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:


N/A


Proxy Voting:

 
10. Name of proxy holder:

N/A
 

11. Number of voting rights proxy holder will cease to hold:


 

12. Date on which proxy holder will cease to hold voting rights:


 

13. Additional information:


 

14. Contact name:

SHELBY DRESCHER
 

15. Contact telephone number:

+1 212 483 7070


For notes on how to complete form TR-1 please see the FSA website.



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END

HOLUSOWRWBRSURR
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Celadon Pharmaceuticals Charts.
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Celadon Pharmaceuticals Charts.